Vyvanse and Broken bone - a phase IV clinical study of FDA data

Summary:

Broken bone is reported as a side effect among people who take Vyvanse (lisdexamfetamine dimesylate), especially for people who are female, 30-39 old, have been taking the drug for 1 - 6 months also take Cymbalta, and have Migraine.

The phase IV clinical study analyzes which people have Broken bone when taking Vyvanse. It is created by eHealthMe based on reports of 28,083 people who have side effects when taking Vyvanse from the FDA, and is updated regularly.

What is Vyvanse?

Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,868 Vyvanse users. Check the latest studies of Vyvanse.

What is Broken bone?

Broken bone is found to be associated with 1,304 drugs and 1,491 conditions by eHealthMe. Check the latest studies of Broken bone.

On Jul, 16, 2026

28,083 people reported to have side effects when taking Vyvanse.
Among them, 13 people (0.05%) have Broken bone.

Among these 13 people:

How long have people been on Vyvanse when they have Broken bone? *

What is the gender of people who have Broken bone when taking Vyvanse? *

female: 62.5 %
male: 37.5 %

What is the age of people who have Broken bone when taking Vyvanse? *

What are other drugs people take besides Vyvanse? *

What are other side effects people have besides Broken bone? *

Pain: 6 people, 46.15%
High Blood Pressure: 4 people, 30.77%
Nausea And Vomiting: 4 people, 30.77%
Headache (pain in head): 4 people, 30.77%
Feeling Abnormal: 4 people, 30.77%
Drowsiness: 4 people, 30.77%
Cystitis Haemorrhagic (blood in the urine and painful voiding): 4 people, 30.77%
Rashes (redness): 4 people, 30.77%
Pain In Extremity: 4 people, 30.77%
Nausea (feeling of having an urge to vomit): 4 people, 30.77%

What are the existing conditions these people have? *

High Blood Pressure: 4 people, 30.77%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 30.77%
Migraine (headache): 4 people, 30.77%
Hiv Infection: 2 people, 15.38%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 15.38%
Bacterial Infection: 2 people, 15.38%
Cough: 2 people, 15.38%
Fungal Infection: 2 people, 15.38%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 15.38%
Stress And Anxiety: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Vyvanse and have Broken bone?

- Check whether Broken bone is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vyvanse:

Vyvanse (35,868 reports)

Broken bone treatments and more:

Broken bone (35,552 reports)

Browse all side effects of Vyvanse:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Broken bone:

Broken bone (1,304 drugs)

Browse all the conditions that are associated with Broken bone:

Broken bone (1,491 conditions)

Related publications that referenced our studies

Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on lisdexamfetamine dimesylate (the active ingredients of Vyvanse) and Vyvanse (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.